Inimex Pharmaceuticals Inc. Announces Series A Venture Capital Financing
10/19/2005 5:08:58 PM
Inimex Pharmaceuticals today announced the first closing of a Series A Financing for US$4.5 million (C$6.0 million) led by a syndicate of venture capital funds: BDC Venture Capital, the Canadian Medical Discoveries Fund (CMDF) advised by MDS Capital, and the Working Opportunity Fund managed by GrowthWorks(TM) Capital. Proceeds of the financing will support the lead optimization and pre-clinical development of the first drug based on Inimex' novel innate immunity platform.